MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

MDT

94.99

-0.35%↓

VEEV

292.58

+1.89%↑

A

140.97

+1.06%↑

HQY

90.94

-1.4%↓

TLRY

1.54

-8.33%↓

Search

IQVIA Holdings Inc

Open

SectorGezondheidszorg

204.99 0.54

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

203.15

Max

207.95

Belangrijke statistieken

By Trading Economics

Inkomsten

17M

266M

Verkoop

188M

4B

K/W

Sectorgemiddelde

29.532

36.442

Winstmarge

6.622

Werknemers

90,000

EBITDA

28M

781M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+7.99% upside

Dividenden

By Dow Jones

Volgende Winsten

28 okt 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

7.1B

35B

Vorige openingsprijs

204.45

Vorige sluitingsprijs

204.99

Nieuwssentiment

By Acuity

50%

50%

166 / 371 Rangschikking in Healthcare

Technische score

By Trading Central

Vertrouwen

Bullish Evidence

IQVIA Holdings Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

15 okt 2025, 23:25 UTC

Belangrijke Marktbewegers

Salesforce Rises on New FY30 Financial Targets

15 okt 2025, 18:52 UTC

Winsten
Belangrijke Marktbewegers

Prologis Shares Gain on Raised Outlook, Data Center Growth

15 okt 2025, 18:30 UTC

Acquisities, Fusies, Overnames

Constellation Software to Buy U.K.'s Tecvia Holding

15 okt 2025, 17:19 UTC

Acquisities, Fusies, Overnames

Drahi's Altice Rejects $20 Billion Joint Offer From Peers -- 2nd Update

15 okt 2025, 17:11 UTC

Acquisities, Fusies, Overnames

Anglo American, MMG Offer Concessions to EU Merger Watchdog in Nickel Deal Probe

15 okt 2025, 23:48 UTC

Marktinformatie

Gold Steady, Supported by Expectations of Ongoing Central Bank Purchases -- Market Talk

15 okt 2025, 23:38 UTC

Marktinformatie

Nikkei May Rise, Tracking Gains Across Most U.S. Equity Markets -- Market Talk

15 okt 2025, 22:37 UTC

Marktinformatie

Economic Stars Are Aligning for RBA -- Market Talk

15 okt 2025, 21:44 UTC

Winsten

Stock Rally Is Lifting Wealth Managers. How Much Is Charles Schwab Benefiting? -- Barrons.com

15 okt 2025, 20:50 UTC

Marktinformatie
Winsten

Financial Services Roundup: Market Talk

15 okt 2025, 20:44 UTC

Acquisities, Fusies, Overnames

Restaurant Brands Recommends Hldrs Do Not Tender Their Shrs to the Offer >QSR.T

15 okt 2025, 20:44 UTC

Acquisities, Fusies, Overnames

Restaurant Brands Notified of Unsolicited Mini-Tender Offer to Buy Shrs at $28.80/Shr

15 okt 2025, 20:43 UTC

Acquisities, Fusies, Overnames

Restaurant Brands Notified of Unsolicited Mini-Tender Offer by NY Stk and Bond LLC to Purchase Up to 10,000 Common Shrs >QSR.T

15 okt 2025, 20:34 UTC

Winsten

Prologis Raises Outlook as Warehouse Leasing Picks Up -- WSJ

15 okt 2025, 20:31 UTC

Acquisities, Fusies, Overnames

RBI Recommends Hldrs Reject NYSB's "Mini-Tender Offer"

15 okt 2025, 20:17 UTC

Acquisities, Fusies, Overnames

GE Vernova Stock Feill With Latest Call to Sell -- Barrons.com

15 okt 2025, 19:06 UTC

Winsten

These Stocks Are Moving the Most Today: Bank of America, Morgan Stanley, ASML, AMD, Nvidia, Bunge, Progressive, Abbott, and More -- Barrons.com

15 okt 2025, 19:04 UTC

Marktinformatie

Oil Futures Post Back-to-Back Losses -- Market Talk

15 okt 2025, 18:46 UTC

Marktinformatie

U.S. Natural Gas Futures Slip Ahead of Storage Data -- Market Talk

15 okt 2025, 18:23 UTC

Winsten

This Insurer Is the One of the Worst Stocks in the S&P 500 Today. Here's Why. -- Barrons.com

15 okt 2025, 17:37 UTC

Acquisities, Fusies, Overnames

Constellation Software's Harris Operating Group Enters Into Agreement To Acquire TECVIA Holding GmbH >CSU.T

15 okt 2025, 17:34 UTC

Marktinformatie

Oil Futures Lose Ground on Trade, Oversupply Concerns -- Market Talk

15 okt 2025, 16:57 UTC

Winsten

The Nation's Biggest Banks Are Saying the Economy Is Still Strong -- WSJ

15 okt 2025, 16:51 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Doesn't Disclose Financial Details

15 okt 2025, 16:50 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: RetinAI Partners With Pharmaceutical Companies, Research Organizations

15 okt 2025, 16:49 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: Deal Reinforces the Group's Med-Tech Journey

15 okt 2025, 16:48 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: Ikerian Specializes in Artificial Intelligence, Data Management in Eyecare

15 okt 2025, 16:48 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica: Ikerian Is a Health Technology Company, Operating Under the RetinAI Brand

15 okt 2025, 16:47 UTC

Acquisities, Fusies, Overnames

EssilorLuxottica Buys Ikerian

15 okt 2025, 16:34 UTC

Marktinformatie

AMD Data Center Agreements Will Provide Big Revenue Growth -- Market Talk

Peer Vergelijking

Prijswijziging

IQVIA Holdings Inc Prognose

Koersdoel

By TipRanks

7.99% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 221.13 USD  7.99%

Hoogste 240 USD

Laagste 200 USD

Gebaseerd op 18 Wall Street-analisten die 12-maands prijsdoelen bieden voor IQVIA Holdings Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

18 ratings

14

Buy

4

Hold

0

Sell

Technische score

By Trading Central

150.68 / 153.45Steun & Weerstand

Korte Termijn

Bullish Evidence

Gemiddeld Termijn

Neutral Evidence

Lange Termijn

Bearish Evidence

Sentiment

By Acuity

166 / 371 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.
help-icon Live chat